Schmidt, K.L.J.; Dautzenberg, N.M.M.; Hoogerbrugge, P.M.; Lindemans, C.A.; Nierkens, S.; Smits, G.; Van Binnendijk, R.S.; Bont, L.J.; Tissing, W.J.E.
Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients. Cancers 2023, 15, 2562.
https://doi.org/10.3390/cancers15092562
AMA Style
Schmidt KLJ, Dautzenberg NMM, Hoogerbrugge PM, Lindemans CA, Nierkens S, Smits G, Van Binnendijk RS, Bont LJ, Tissing WJE.
Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients. Cancers. 2023; 15(9):2562.
https://doi.org/10.3390/cancers15092562
Chicago/Turabian Style
Schmidt, K. L. Juliëtte, Noël M. M. Dautzenberg, Peter M. Hoogerbrugge, Caroline A. Lindemans, Stefan Nierkens, Gaby Smits, Rob S. Van Binnendijk, Louis J. Bont, and Wim J. E. Tissing.
2023. "Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients" Cancers 15, no. 9: 2562.
https://doi.org/10.3390/cancers15092562
APA Style
Schmidt, K. L. J., Dautzenberg, N. M. M., Hoogerbrugge, P. M., Lindemans, C. A., Nierkens, S., Smits, G., Van Binnendijk, R. S., Bont, L. J., & Tissing, W. J. E.
(2023). Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients. Cancers, 15(9), 2562.
https://doi.org/10.3390/cancers15092562